Postanesthesia Care

Latest Issue of OR Manager
January 2025
Home Postanesthesia Care

FDA: Class I recall of certain Philips Respironics ventilators

Editor's Note The Food and Drug Administration (FDA) on February 16 identified the recall by Philips Respironics of certain reworked Trilogy 100, Trilogy 200, and Garbin Plus ventilators as Class I, the most serious. The recall was initiated because of the potential for silicone foam adhesive failure and residual polyester-based…

Read More

By: Judy Mathias
February 21, 2023
Share

FDA: Class I recall of Smiths Medical CADD Infusion System Administration Sets, Cassette Reservoirs

Editor's Note The Food and Drug Administration (FDA) on February 2 identified the recall by Smiths Medical of certain CADDTM Infusion System Administration Sets and Cassette Reservoirs as Class I, the most serious. The recall was initiated because of tubing occlusion and false “no disposable attached” alarm issues, which may…

Read More

By: Judy Mathias
February 10, 2023
Share

The Joint Commission announces new search site for SUD treatment providers

Editor's Note The Joint Commission on February 1 announced a new search site that is available for finding Joint Commission-accredited organizations that provide substance use disorder (SUD) treatment and the levels of care they provide. Individuals seeking care, providers, state authorities, and payers can search by organization name or location…

Read More

By: Judy Mathias
February 3, 2023
Share

Effect of postop anesthesia personnel visits on mortality

Editor's Note This study from the Netherlands finds the addition of postoperative visits by anesthesia personnel (anesthesiologists or residents) to routine monitoring with modified early warning scores (MEWS) did not reduce 30-day mortality. A total of 5,190 (2,490 control, 2,700 intervention) medium- to high-risk elective surgical patients from nine academic…

Read More

By: Judy Mathias
February 2, 2023
Share

Sponsored Message

FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters

Editor's Note The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious. The recall was initiated because of a potential catheter hub defect that may cause…

Read More

By: Judy Mathias
February 1, 2023
Share

FDA: Class I recall of Datascope/Getinge Cardiosave Hybrid, Rescue IABPs

Editor's Note The Food and Drug Administration (FDA) on January 25 identified the recall by Datascope/Gettinge of its Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The recall was initiated because of the risk that blood may enter the pump through a damaged balloon…

Read More

By: Judy Mathias
January 26, 2023
Share

Sponsored Message

Inequities in cancer treatments after COVID-19 infection

Editor's Note This study led by researchers at Columbia University Irving Medical Center, New York City, finds that race, ethnicity, and area-level social determinants of health (SDOH) were associated with delayed or discontinued cancer treatments and longer delays to restart drug-based therapies after COVID-19 infections. The analysis included data on…

Read More

By: Judy Mathias
January 19, 2023
Share

ECRI lists Top 10 Health Technology Hazards for 2023

Editor's Note ECRI on January18 published its Top 10 Health Technology Hazards report for 2023, which includes: Gaps in recalls for at-home medical devices Defective single-use medical devices Automated dispensing cabinet overrides Undetected venous needle dislodgement Cybersecurity risks associated with cloud-based clinical systems Inflatable pressure infusers Confusion about ventilator cleaning…

Read More

By: Judy Mathias
January 19, 2023
Share

Pediatric patients benefit from calming, quiet OR environment

Takeaways • Children are not small adults. Greater attention should be paid to their fears and anxiety, and equipment and medication should be tailored to meet their needs. • All staff should have Pediatric Advanced Life Support (PALS) certification. • ASCs can use toys and games as distractions to ease…

Read More

By: Jennifer Lubell
January 19, 2023
Share

ERAS patients are prescribed fewer postdischarge opioids

Editor's Note This study by researchers at the Massachusetts General Hospital, Boston, finds that patients participating in an Enhanced Recovery after Surgery (ERAS) program were prescribed significantly fewer opioids at discharge, compared to patients before ERAS was instituted. A total of 3,983 patients were included (1,929 pre-ERAS and 2,054 post-ERAS).…

Read More

By: Judy Mathias
January 12, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat